Retinoic Acids and Cytokines in Hematopoiesis

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1 R43 CA63940-01A1,
Agency Tracking Number: 29191
Amount: $99,856.00
Phase: Phase I
Program: SBIR
Awards Year: 1995
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
4100 S Kettering Boulevard, Dayton, OH, 45439
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Yisheng Wang
 () -
Business Contact
Phone: () -
Research Institution
This Phase I application is concerned with the secretion of G-CSF by bone marrow mononuclear cellsstimulation by a combination of retinoids and natural product extract from a Chinese fungus . Retinoto prevent and treat certain types of cancers while the FE is used in traditional Chinese medicine tof high dose chemotherapy and radiation therapy. These investigators have already shown that FE stimGM and the release of cytokines from bone marrow cells. They have also shown that all-trans retinoicstimulation of G-CSF secretion by FE, while inhibiting the induced secretion of GM-CSF and TNF-alphadependent fashion. Other retinoids were also active, including 9-cis retinoic acid as well as vitamihowever, a non- specific result of exposure to steroids, since T3 and beta-estradiol did not shown selucidate the mechanism of interaction between retinoids and FE in inducing D3-CSF secretion.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government